IP Library Granted Patent US 9,766,201
Granted Patent B2
US 9,766,201 · App. 15/081,491 · Granted Sep 19, 2017

Systems and methods for detecting a substance in bodily fluid

Inventors: Meike Herget (Woodside, CA); Oren S. Knopfmacher (Palo Alto, CA)
Assignee: Avails Medical, Inc.
G01N27/4145G01N27/60G01N33/54353G01N33/54373G01N33/54386
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,766,201
App. No.
15/081,491
Granted
Sep 19, 2017
Kind
B2
Abstract

Various devices, systems and methods for determining a parameter of and/or detecting chemical and biological substances in bodily fluid are described herein. A device or system may include a substrate. An active sensor having an electrical characteristic and/or a control sensor may be disposed on the substrate. In certain variations, a differential between a first signal from the active sensor, and a second signal from the control sensor may be used to determine a parameter of the chemical or biological substance in the sample of bodily fluid.

Claims (22)

1. A method for determining a parameter of a substance in a sample, the method comprising:

providing a substrate comprising an active sensor and a control sensor,

wherein the active sensor comprises a first electrical component having a first electrical characteristic and at least one functionalized structure in electrical communication with the first electrical component, wherein the functionalized structure includes a number of binding receptors, wherein the binding receptors comprise engineered proteins, wherein the functionalized structure is coupled to a portion of the substrate in a vicinity of the active sensor, and wherein the portion of the substrate in the vicinity of the active sensor is an area of the substrate separated from the active sensor, and

wherein the control sensor comprises a second electrical component having a second electrical characteristic;

introducing the sample to the substrate, wherein introducing the sample results in binding of the substance to the binding receptors and results in the release of ions such that the release of ions results in a change in the first electrical characteristic of the first electrical component;

comparing the first electrical characteristic of the first electrical component with the second electrical characteristic of the second electrical component;

using the comparison to determine at least one parameter of the substance in the sample; and

producing an output of the at least one parameter.

2. The method of claim 1 , wherein the functionalized structure includes a permeable membrane, hydrogel, PVC, or other filter, for allowing only the passage of a target moiety.

3. The method of claim 1 , wherein the control sensor includes a passivation structure such as a self-assembled monolayer (SAM), metal layer, polymer layer, or any biochemically inert material.

4. The method of claim 1 , wherein the parameter of the substance in the sample determined by the comparison of the first electrical characteristic and the second electrical characteristic is concentration.

5. The method of claim 1 , wherein the substance includes a therapeutic , drug, biological moiety, chemical moiety, toxin, ion, antibody, peptide, oligonucleotide, pathogen, cells, or natural or engineered ligands.

6. The method of claim 1 , wherein comparing the first electrical characteristic of the first electrical component with the second electrical characteristic of the second electrical component includes comparing at least one of a frequency, current, voltage, resistance, impedance, capacitance, conductivity, induction, threshold voltage, transconductance, subthreshold swing, piezo-resistivity, magnetic field, and electrical noise of the first electrical component with that of the second electrical component.

7. The method of claim 1 , wherein the at least one parameter of the substance in the sample is concentration.

8. The method of claim 1 , wherein the first electrical component comprises at least one of a transistor, a capacitor, a resistor, and an inverter.

9. The method of claim 1 , wherein the second electrical component comprises at least one of a transistor, a capacitor, a resistor, and an inverter.

10. The method of claim 1 , wherein the active sensor is covered by at least one of a noble metal layer, a nanoparticle layer, and an organic layer.

11. The method of claim 1 , wherein the binding receptor is configured to interact with the substance to undergo a reaction resulting in the release of ions and the release of ions affects the first electrical characteristic of the first electrical component.

12. The method of claim 11 , wherein the reaction resulting in the release of ions comprises:

the binding receptor binding the substance;

introducing a first molecule having a second binding receptor to the active sensor, wherein the second binding receptor binds to a different site of the substance bound by the binding receptor; and

introducing a second molecule to the active sensor, wherein the introduction of the first molecule having the second binding receptor and the second molecule to the active sensor results in an enzymatic reaction that releases ions.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2017
From: AVAILS MEDICAL, INC.
To: ESENSE, LLC
Reel/Frame 044467/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2016
From: HERGET, MEIKE; KNOPFMACHER, OREN S.
To: AVAILS MEDICAL, INC.
Reel/Frame 038104/0809 →
Continuity (3)
Continuation 14599190 · Jan 16, 2015
Continuation 14586802 · Dec 30, 2014
Related Publication 20160209356A1 · Jul 21, 2016